10967/276 - QDB Compounds

QsarDB Repository

Zukic, S.; Ivanova, L.; Zusinaite, E.; Merits, A.; Maran, U. Discovery of a Novel Phthalazine-Based VEGFR-2 Inhibitor by Machine Learning Analysis of Diverse Chemical Space with Favorable Pharmacophores and Its Evaluation in Glioblastoma Cell Lines. Results in Chemistry, Under revision

Compound

ID:132
Name:Compound 132
Description:Original numeration in publication: 16
Labels:Training_set, Thiazolidine‐2, 4‐dione
CAS:
InChi Code:InChI=1S/C19H14Cl2N2O3S/c1-11-2-6-14(7-3-11)22-17(24)10-23-18(25)16(27-19(23)26)8-12-4-5-13(20)9-15(12)21/h2-9H,10H2,1H3,(H,22,24)/b16-8-

Properties

pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]

ValueSource or prediction
6.31

El-Adl, K.; Sakr, H.; El-Hddad, S. S. A. a. E.-H., A.-G. A.; Nasser, M.; Abulkhair, H. S. Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2021, 354, e2000491. https://doi.org/10.1002/ardp.202000491

6.05017

Eq1: VEGFR-2 inhibition (Data used to train model)